Wedge Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-621,941
Closed -$30.6M 444
2022
Q1
$30.6M Sell
621,941
-4,994
-0.8% -$264K 0.41% 119
2021
Q4
$35M Buy
626,935
+147,596
+31% +$8.12M 0.43% 90
2021
Q3
$27.8M Buy
479,339
+7,767
+2% +$479K 0.36% 118
2021
Q2
$29.8M Sell
471,572
-37,521
-7% -$2.47M 0.37% 120
2021
Q1
$32.5M Sell
509,093
-10,229
-2% -$593K 0.39% 103
2020
Q4
$27.2M Buy
+519,322
New +$25.6M 0.31% 122
2015
Q3
Sell
-15,150
Closed -$781K 616
2015
Q2
$781K Buy
15,150
+1,250
+9% +$64.7K 0.01% 351
2015
Q1
$707K Buy
13,900
+2,125
+18% +$110K 0.01% 370
2014
Q4
$627K Buy
+11,775
New +$599K 0.01% 411

Other funds holding XRAY

Wedge Capital Management's XRAY Position: Q2 2022 in Review

Wedge Capital Management sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 621,941 shares — an estimated $30.6M sold.

Wedge Capital Management first reported a position in XRAY in Q4 2014 and held it in 9 quarters. The position peaked at $35M in Q4 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Wedge Capital Management reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Wedge Capital Management sold 621,941 Dentsply Sirona shares in Q2 2022, an estimated $30.6M.
  • Wedge Capital Management first reported a position in Dentsply Sirona in Q4 2014 and held it in 9 quarters.
  • Wedge Capital Management's Dentsply Sirona position peaked at $35M in Q4 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Wedge Capital Management's 13F filing for Q2 2022, filed 11 Jul 2022.